
$5.4B+8% YoYFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Revenue reached $5.4B in 2025, compounding +48% a year since 2022 That is 5 straight years of gains. The last twelve months (+14%) ran below that pace, so growth is slowing. The trailing twelve months are already running at $5.9B, ahead of the last full year.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
$-3.6BFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→The company lost $3.6B in 2025, less than the $4.7B it lost the year before. The losses are narrowing, but it is still burning shareholder money.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
+8.4%revenue growth, FY 2025
→Revenue grew +8% in 2025 against a five-year average of +776%.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
$-2.5BFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→The business consumed $2.5B of cash in 2025 after investment. Growth is being funded from the balance sheet, not from operations.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→Of $5.4B in 2025 sales, nothing survives to the bottom line - the journey ends $3.6B underwater.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Free cash flow is negative, so no share of revenue is currently converting to spare cash. Every sales dollar is being reinvested or consumed.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year
→The biggest claim on each sales dollar is capital spending, at 32% of revenue (research and development 31%, stock compensation 14%). That share has fallen since 2022, so the cost of competing is easing.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year
→Operating margin widened 347 points to -67% since 2022. The bottom line is still negative: costs below the operating line eat what is left.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year
→ROE of -63% and ROCE of -32% sit close together, so the returns come from the business itself rather than from borrowing.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
3.6xP/S today
◌ 2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages
→At 3.6x sales, the market is paying about what it has typically paid RIVN's own 4-year median of 3.9x. Neither a bargain nor a stretch by its own standard.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
-16.3%FCF yield today
◌ 2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages
→Every dollar of market value currently buys -16.3% of annual free cash flow, less than its 4-year median of -18.1% - you are paying up for the same cash.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→Debt of $4.4B sits against $3.6B of cash, or 0.9x shareholders' equity. Earnings don't currently cover the interest bill at all.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→The company's own capital shrank from $9.1B in 2023 to $5.1B (-44%). Buybacks or losses are drawing the buffer down - the distinction matters.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→The share count grew 17.1% in 2025, averaging 9.3% a year over three years. Your slice of the company shrinks by that much each year unless earnings grow faster.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→RIVN's return on capital is negative at -32.1% in 2025. The capital in the business is not yet earning anything back.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→Insiders bought $1.0B and sold $3M on the open market, a net purchase of $997M. A further 33 filings were grants, option exercises or tax withholding, which say nothing either way.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30